Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ANAKINRA
- Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
- Therapy Management in Patients Treated With Anakinra Due to Recurrent Pericarditis
- The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)
- Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome
- Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β
- A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
- Therapeutic Approach in Colchicine-resistant Recurrent pEricarditis in Children
- Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
- Colchicine and Inflammation in Hemodialysis Patients
- Anakinra in Dengue With Hyperinflammation ( AnaDen )
- Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease
- The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis
- Canakinumab for the Treatment of Postprandial Hypoglycemia
- Anakinra for Preterm Infants Pilot
- Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19
- Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
- Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure
- Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes
- Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia.
- Discovery and Analytical Validation of Inflammatory Bio-signatures of the Human Pain Experience
- Personalized Immunotherapy in Sepsis
- Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients
- Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)
- MIS-C Comparative Effectiveness Study
- Combination of Baricitinib and Adalimumab in Rheumatoid Arthritis
- Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation
- Studying Anakinra to Reduce Secondary Brain Damage After Spontaneous Haemorrhagic Stroke
- Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)
- Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease
- Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients
- suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19
- A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
- Anakinra in the Management of COVID-19 Infection
- Anakinra, COVID-19, Cytokine Storm
- A Study of JNJ-77474462 in Healthy Participants
- SCIL-1Ra in COVID-19 Feasibility & PK/PD
- Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS)
- Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma
- A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease
- A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study
- Randomised Evaluation of COVID-19 Therapy
- Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation
- Anakinra for COVID-19 Respiratory Symptoms
- Tocilizumab Treatment in Patients With COVID-19
- Early Treatment of Cytokine Storm Syndrome in Covid-19
- suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)
- Efficacy of Tocilizumab on Patients With COVID-19
- CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection
- Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction
- Treatment of COVID-19 Patients With Anti-interleukin Drugs
- IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes
- A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer
- Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma
- A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
- A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy
- IL-1 Receptor Inhibitor for Granulomatous Complications in Patients With Chronic Granulomatous Disease
- Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial
- Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis
- Anakinra as a Rescue Treatment for Allergic Inflammation
- Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
- Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis
- Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms
- Biologic Therapy to Prevent Osteoarthritis After ACL Injury
- A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CF
- Woodsmoke Particulate + Prednisone
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2
- BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage
- Pilot Study of Dapansutrile Capsules in Schnitzler's Syndrome
- Effects of Anakinra in Subjects With Autoimmune Inner Ear Disease
- Effects of Interleukin-1 Receptor Antagonism on Hyperandrogenemia in Women With Polycystic Ovary Syndrome
- Early Phase Administration of Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation
- Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation
- A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis
- A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)
- Anakinra: Safety and Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT
- Treatment of Acute Pericarditis With Anakinra
- Postprandial Hypoglycemia in Patients After Bariatric Surgery With Empagliflozin and Anakinra - The Hypo-BEAR-Study
- Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
- Anti-Cytokine Therapy for Hemodialysis InflammatION
- Islet Transplantation Using PKX-001
- Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease
- Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension
- Tocilizumab in Patients With Schnitzler's Syndrome
- Anakinra Versus Placebo for the Treatment of Acute MyocarditIS
- A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis
- IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions
- Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis
- Role of Interleukin (IL)-1 in Postprandial Fatigue - The Chäschüechli 2 Study
- Kineret in the Treatment of Rheumatoid Arthritis
- Giant Cell Arteritis and Anakinra Trial
- HL2351 CAPS Phase II Study
- Treatment of Macrophage Activation Syndrome (MAS) With Anakinra
- Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA)
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome
- MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB
- Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study
- Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer
- Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist Devices
- Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection
- Aralast NP in Islet Transplant
- Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma
- Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss
- Anakinra and Kawasaki Disease
- IL-1RA, Acute Exercise, and Beta-cell Function
- Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease
- Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2
- Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study
- Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes
- Effects of IL-1 Beta on the HPA-axis in Obese Persons
- AnakInRa for Treatment of Recurrent Idiopathic Pericarditis (AIRTRIP)
- Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease
- Interleukin-1 Blockade in HF With Preserved EF
- Cytokine Inhibition in Chronic Fatigue Syndrome Patients
- Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer
- A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy
- Effects of Intraarticular IL1-Ra on Pain and Inflammatory Mediators After Knee Arhroscopy
- Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3)
- Interleukin-1 Blockade in Recently Decompensated Heart Failure
- Interleukin (IL)-1 Blockade in Acute Heart Failure (Anakinra ADHF)
- Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis
- Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study
- Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis
- Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients
- Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)
- Anakinra for Inflammatory Pustular Skin Diseases
- Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever
- Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers
- Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease
- Anakinra in Hidradenitis Suppurativa
- Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction
- Anakinra as a Treatment for Hydradenitis Suppurativa
- Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension
- Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes
- Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain
- Anakinra for Behcet s Disease
- Effect of Interleukin-1 Receptor Antagonist on Inhalation of 20,000 EU Clinical Ctr Reference Endotoxin in Normal Volunteers
- Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure
- Effect of Anakinra on Insulin Sensitivity in Type 1 Diabetes Mellitus
- The Effect of Anakinra on Insulin Secretion
- Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral Sclerosis
- Efficacy and Safety of Canakinumab in Schnitzler Syndrome
- A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease
- Ilaris (Canakinumab) in the Schnitzler Syndrome
- A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease
- Anakinra to Prevent Adverse Post-infarction Remodeling (2)
- Anakinra in Myositis
- A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis
- Tocilizumab for Relapsing Polychondritis
- Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study
- Interleukin-1 Receptor Antagonist and Insulin Sensitivity
- Anakinra to Prevent Post-infarction Remodeling
- Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease
- Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis
- Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis
- Anti-Interleukin-1 in Diabetes Action
- Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens Syndrome
- A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis
- Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes
- Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma
- The SPECTRA Study
- The Efficacy and Safety of ITF2357 in AIS
- Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients
- Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate
- Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
- Study to Prevent Cartilage Damage Following Acute Knee Injury.
- The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria
- Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis
- Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported Questionnaire
- Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)
- Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA)
- Treatment for Patients With Osteoarthritis (OA) of the Knee
- Interleukin-1 Trap to Treat Autoinflammatory Diseases
- Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
- Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis
- Juvenile Rheumatoid Arthritis
Clinical trials list
click for details